Follow
Jacques Brown
Jacques Brown
CHUL Research Centre
Verified email at crchudequebec.ulaval.ca
Title
Cited by
Cited by
Year
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial
ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, ...
Jama 282 (14), 1344-1352, 1999
32501999
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
JP Brown, RG Josse, ...
Canadian Medical Association Journal 167 (10 suppl), S1-S34, 2002
16832002
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ...
New England Journal of Medicine 339 (5), 292-299, 1998
15821998
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ...
Osteoporosis international 18 (8), 1033-1046, 2007
14822007
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus
AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ...
Journal of Bone and Mineral Research 30 (1), 3-23, 2015
14432015
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
A Papaioannou, S Morin, AM Cheung, S Atkinson, JP Brown, S Feldman, ...
Canadian Medical Association Journal 182 (17), 1864-1873, 2010
13842010
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
D Liu, A Ahmet, L Ward, P Krishnamoorthy, ED Mandelcorn, R Leigh, ...
Allergy, Asthma & Clinical Immunology 9 (1), 30, 2013
12352013
Romosozumab in postmenopausal women with low bone mineral density
MR McClung, A Grauer, S Boonen, MA Bolognese, JP Brown, ...
New England Journal of Medicine 370 (5), 412-420, 2014
12322014
Intravenous zoledronic acid in postmenopausal women with low bone mineral density
IR Reid, JP Brown, P Burckhardt, Z Horowitz, P Richardson, U Trechsel, ...
New England Journal of Medicine 346 (9), 653-661, 2002
11142002
Canadian normative data for the SF-36 health survey
WM Hopman, T Towheed, T Anastassiades, A Tenenhouse, S Poliquin, ...
Canadian Medical Association Journal 163 (3), 265-271, 2000
9662000
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
JD Adachi, WG Bensen, J Brown, D Hanley, A Hodsman, R Josse, ...
New England Journal of Medicine 337 (6), 382-388, 1997
9411997
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
HG Bone, RB Wagman, ML Brandi, JP Brown, R Chapurlat, ...
The Lancet Diabetes & Endocrinology, 2017
9032017
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 …
JP Brown, RL Prince, C Deal, RR Recker, DP Kiel, LH De Gregorio, ...
Journal of bone and mineral research 24 (1), 153-161, 2009
7902009
Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial
JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ...
Arthritis & Rheumatology 44 (1), 202-211, 2001
7162001
A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX
EV McCloskey, A Odén, NC Harvey, WD Leslie, D Hans, H Johansson, ...
Journal of bone and mineral research 31 (5), 940-948, 2016
6672016
Recurrent Mutation of the Gene Encoding sequestosome 1 (SQSTM1/p62) in Paget Disease of Bone
N Laurin, JP Brown, J Morissette, V Raymond
The American Journal of Human Genetics 70 (6), 1582-1588, 2002
6552002
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy
S Wallach, S Cohen, DM Reid, RA Hughes, DJ Hosking, RF Laan, ...
Calcified Tissue International 67 (4), 277-285, 2000
6132000
Vertebral Fractures Following Discontinuation of Denosumab: a Post‐hoc Analysis of the Randomized Placebo‐controlled FREEDOM Trial and its Extension
SR Cummings, S Ferrari, R Eastell, N Gilchrist, JE Beck Jensen, ...
Journal of Bone and Mineral Research, 2017
590*2017
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
DL Kendler, C Roux, CL Benhamou, JP Brown, M Lillestol, S Siddhanti, ...
Journal of Bone and Mineral Research 25 (1), 72-81, 2010
5782010
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
G Ioannidis, A Papaioannou, WM Hopman, N Akhtar-Danesh, ...
Canadian Medical Association Journal 181 (5), 265-271, 2009
5412009
The system can't perform the operation now. Try again later.
Articles 1–20